Table 2 CMR data by reperfusion therapy
Variable | Group 1, n = 47 (PPCI) | Group 2, n = 12 (Thrombolysis) | Group 3, n = 8 (Rescue-PCI) | Group 4, n = 6 (Late PCI) | Group 5, n = 21 (Non-reperfused) | p | p (corrected for TTR) |
|---|---|---|---|---|---|---|---|
Time admission-CMR (d) | 1.8 (1.1-2.6) | 2.2 (1.3-2.6) | 1.9 (1.4-3.8) | 1.9 (1.5-3.6) | 6.6 (4.8-11.0) | <0.001 | -- |
LVEDVI (ml/m2) | 91.6 (84.9-102.7) | 83.8 (76.1-107.6) | 99.7 (88.5-116.6) | 99.3 (83.7-106.7) | 98.0 (88.1-125.0) | 0.08a | 0.44a |
LVESVI (ml/m2) | 51.3 (47.5-62.6) | 55.1 (38.1-80.6) | 63.1 (48.9-79.7) | 64.1 (52.8-71.6) | 61.1 (54.0-83.6) | 0.03 a | 0.39a |
LVMI (g/m2) | 50.0 (47.4-55.7) | 46.3 (42.8-67.3) | 50.9 (43.2-56.7) | 48.8(42.0-59.6) | 58.0 (50.4-63.9) | 0.24a | 0.96a |
LVEF (%) | 42.0 ± 7.9 | 43.3 ± 7.5 | 36.5 ± 9.4 | 37.1 ± 10.0 | 35.0 ± 11.3 | 0.02 | 0.34 |
AAR (%LVM) | 48.6 (35.9-66.5) | 63.0 (49.7-65.3) | 56.8 (37.6-67.7) | 89.2 (77.2-98.1) | n/a | 0.001 | 0.05 |
IS (%LVM) | 25.4 ± 16.0 | 20.5 ± 12.5 | 39.8 ± 21.8 | 47.4 ± 22.7 | 23.8 ± 11.5 | 0.02a | 0.33a |
MVO presence (%) | 26 (55.3%) | 7 (58.3%) | 5 (62.5%) | 6 (100%) | 15 (71.4%) | NS | -- |
MVO (%LVM) | 0.5 (0.0-3.3) | 0.2 (0.0-3.9) | 1.2 (0.0-4.6) | 6.4 (1.0-14.8) | 1.3 (0.0-2.8) | 0.08 | 0.37 |